SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-022736
Filing Date
2024-03-15
Accepted
2024-03-14 19:35:44
Documents
17
Period of Report
2024-03-15
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea0201831-8k_60degree.htm   iXBRL 8-K 28583
2 PRESS RELEASE OF 60 DEGREES PHARMACEUTICALS, INC. DATED AS OF MARCH 14, 2024 ea020183101ex99-1_60degree.htm EX-99.1 35387
3 GRAPHIC ex99-1_001.jpg GRAPHIC 4097
  Complete submission text file 0001213900-24-022736.txt   294507

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE sxtp-20240315.xsd EX-101.SCH 3792
5 XBRL DEFINITION FILE sxtp-20240315_def.xml EX-101.DEF 26654
6 XBRL LABEL FILE sxtp-20240315_lab.xml EX-101.LAB 36762
7 XBRL PRESENTATION FILE sxtp-20240315_pre.xml EX-101.PRE 25278
19 EXTRACTED XBRL INSTANCE DOCUMENT ea0201831-8k_60degree_htm.xml XML 5713
Mailing Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036
Business Address 1025 CONNECTICUT AVENUE NW SUITE 1000 WASHINGTON DC 20036 202-327-5422
60 DEGREES PHARMACEUTICALS, INC. (Filer) CIK: 0001946563 (see all company filings)

IRS No.: 452406880 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41719 | Film No.: 24752014
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)